Katalin Csiszar to Head and Neck Neoplasms
This is a "connection" page, showing publications Katalin Csiszar has written about Head and Neck Neoplasms.
Connection Strength
0.544
-
G?r?gh T, Weise JB, Holtmeier C, Rudolph P, Hedderich J, Gottschlich S, Hoffmann M, Ambrosch P, Csiszar K. Selective upregulation and amplification of the lysyl oxidase like-4 (LOXL4) gene in head and neck squamous cell carcinoma. J Pathol. 2007 May; 212(1):74-82.
Score: 0.277
-
Martin A, Salvador F, Moreno-Bueno G, Florist?n A, Ruiz-Herguido C, Cuevas EP, Morales S, Santos V, Csiszar K, Dubus P, Haigh JJ, Bigas A, Portillo F, Cano A. Lysyl oxidase-like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression. EMBO J. 2015 Apr 15; 34(8):1090-109.
Score: 0.120
-
Weise JB, Rudolph P, Heiser A, Kruse ML, Hedderich J, Cordes C, Hoffmann M, Brant O, Ambrosch P, Csiszar K, G?r?gh T. LOXL4 is a selectively expressed candidate diagnostic antigen in head and neck cancer. Eur J Cancer. 2008 Jun; 44(9):1323-31.
Score: 0.075
-
Weise JB, Csiszar K, Gottschlich S, Hoffmann M, Schmidt A, Weingartz U, Adamzik I, Heiser A, Kabelitz D, Ambrosch P, G?r?gh T. Vaccination strategy to target lysyl oxidase-like 4 in dendritic cell based immunotherapy for head and neck cancer. Int J Oncol. 2008 Feb; 32(2):317-22.
Score: 0.073